Comparative Biosciences’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

CBI is a biomedical firm that provides toxicology, efficacy, pharmacology, dermatology, and fibrosis research solutions for the healthcare industry. Read more

Carol Meschter's photo - Founder & CEO of Comparative Biosciences

Founder & CEO

Carol Meschter

CEO Approval Rating

90/100

Founded:

1996

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 10 a good estimate for Comparative Biosciences's Employee count?

Acquisitions

No recent acquisitions found related to Comparative Biosciences

Comparative Biosciences Funding History

$350K

Since Comparative Biosciences was founded in 1996, it has participated in 1 round of funding. In total Comparative Biosciences has raised $350.0K. Comparative Biosciences' funding round was on Apr 2020 for a total of $350.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$350K - $1M

U.S. Small Business Administration.

Total Funding: $350K

Since Comparative Biosciences was founded in 1996, it has participated in 1 round of funding. In total Comparative Biosciences has raised $350.0K. Comparative Biosciences' funding round was on Apr 2020 for a total of $350.0K

Investments

No recent investments found related to Comparative Biosciences

Comparative Biosciences News

Comparative Biosciences Blogs

January 15, 2019Comparative Biosciences Blog

Pompe Disease

Pompe disease is caused by pathogenic variations in the acid alpha-glucosidase (GAA) gene. Close to 5... See more »
October 9, 2018Comparative Biosciences Blog

Fibrosis and Inflammation

<div class="container"> <a href="http://www.compbio.com/wp-content/uploads/2018/02/broncho_D.png"><im... See more »
August 22, 2018Comparative Biosciences Blog

CBI Published Article

CBI-In Vivo Efficacy Study Showing Comparative Advantage of Bacterial Infection Prevention ... See more »
August 22, 2018Comparative Biosciences Blog

test mr

Cannabis Pharmacology. Cannabis Pharmacology. Assessment of Cannabis Products for Purity, E... See more »
May 31, 2018Comparative Biosciences Blog

Model of Murine Pulmonary Aspergillosis

Model of Murine Pulmonary Aspergillosis Murine models of pulmonary aspergillosis ... See more »
May 30, 2018Comparative Biosciences Blog

Model of Murine Hypersensitivity Pneumonitis

Model of Murine Hypersensitivity Pneumonitis (Farmer's Lung) Murine models of pulmo... See more »
May 30, 2018Comparative Biosciences Blog

Murine Model of Pulmonary Fibrosis and Chronic Inflammation

Murine Model of Pulmonary Fibrosis and Chronic Inflammation Murine models of granulom... See more »

Headquarters

786 Lucerne Dr

Sunnyvale, California94085

408-738-9260

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

CBI is a biomedical firm that provides toxicology, efficacy, pharmacology, dermatology, and fibrosis research solutions for the healthcare industry. Comparative Biosciences was founded in 1996. Comparative Biosciences' headquarters is located in Sunny...

CEO

Comparative Biosciences's Founder & CEO, Carol Meschter, currently has an approval rating of 90%. Comparative Biosciences's primary competitors are

Website

compbio.com

Frequently Asked Questions about Comparative Biosciences

  1. When was Comparative Biosciences founded?

    Comparative Biosciences was founded in 1996
  2. Who is Comparative Biosciences's CEO?

    Comparative Biosciences's CEO is Carol Meschter
  3. How much revenue does Comparative Biosciences generate?

    Comparative Biosciences generates $10M in revenue
  1. How much funding does Comparative Biosciences have?

    Comparative Biosciences has historically raised $350K in funding
  2. Where is Comparative Biosciences's headquarters?

    Comparative Biosciences's headquarters is in Sunnyvale California, USA
  3. How many employees does Comparative Biosciences have?

    Comparative Biosciences has 10 employees